RHO and Leber congenital amaurosis: In a recent phase I/II clinical trial, a specific ASO showed good results in treating Leber congenital amaurosis 10, Usher syndrome type 2 and (rhodopsin) RHO-associated autosomal-dominant retinitis pigmentosa [188].